MedTrace Logo

Prospective Registry on User Experience With The Mapping System For Ablation Procedures

NCT02698670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 577

Last updated 2018-01-25

No results posted yet for this study

Summary

This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.

Conditions

Interventions

DEVICE

Rhythmia mapping system

A 3-D Cardiac Mapping system

DEVICE

IntellaMap Orion mapping catheter

A diagnostic basket mapping catheter

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Gerhard Hindricks · Gerhard Hindricks

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-25
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States
  • Australia
  • France
  • Germany
  • Hong Kong
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698670 on ClinicalTrials.gov